JP2013544799A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544799A5
JP2013544799A5 JP2013535215A JP2013535215A JP2013544799A5 JP 2013544799 A5 JP2013544799 A5 JP 2013544799A5 JP 2013535215 A JP2013535215 A JP 2013535215A JP 2013535215 A JP2013535215 A JP 2013535215A JP 2013544799 A5 JP2013544799 A5 JP 2013544799A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
compound
pharmaceutical composition
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013535215A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013544799A (ja
JP6007186B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2011/001179 external-priority patent/WO2012097427A1/en
Publication of JP2013544799A publication Critical patent/JP2013544799A/ja
Publication of JP2013544799A5 publication Critical patent/JP2013544799A5/ja
Application granted granted Critical
Publication of JP6007186B2 publication Critical patent/JP6007186B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013535215A 2010-10-27 2011-10-26 がん治療のための化合物および組成物 Expired - Fee Related JP6007186B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40706910P 2010-10-27 2010-10-27
US61/407,069 2010-10-27
PCT/CA2011/001179 WO2012097427A1 (en) 2010-10-27 2011-10-26 Compounds and compositions for the treatment of cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016153378A Division JP6371344B2 (ja) 2010-10-27 2016-08-04 がん治療のための化合物および組成物

Publications (3)

Publication Number Publication Date
JP2013544799A JP2013544799A (ja) 2013-12-19
JP2013544799A5 true JP2013544799A5 (enExample) 2014-12-11
JP6007186B2 JP6007186B2 (ja) 2016-10-12

Family

ID=46515034

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013535215A Expired - Fee Related JP6007186B2 (ja) 2010-10-27 2011-10-26 がん治療のための化合物および組成物
JP2016153378A Expired - Fee Related JP6371344B2 (ja) 2010-10-27 2016-08-04 がん治療のための化合物および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016153378A Expired - Fee Related JP6371344B2 (ja) 2010-10-27 2016-08-04 がん治療のための化合物および組成物

Country Status (24)

Country Link
US (2) US9114118B2 (enExample)
EP (2) EP2632452B1 (enExample)
JP (2) JP6007186B2 (enExample)
KR (2) KR101943280B1 (enExample)
CN (2) CN105997967B (enExample)
AU (2) AU2011356583C1 (enExample)
BR (1) BR112013010507A2 (enExample)
CA (1) CA2816093C (enExample)
CL (1) CL2013001152A1 (enExample)
DK (2) DK3443957T3 (enExample)
EA (2) EA030038B1 (enExample)
ES (2) ES2837599T3 (enExample)
IL (2) IL225599A (enExample)
MX (2) MX381345B (enExample)
MY (2) MY162420A (enExample)
NZ (1) NZ610851A (enExample)
PH (2) PH12013500766B1 (enExample)
PL (2) PL2632452T3 (enExample)
PT (2) PT2632452T (enExample)
SG (2) SG10201807622WA (enExample)
TR (1) TR201819987T4 (enExample)
TW (2) TWI578983B (enExample)
WO (1) WO2012097427A1 (enExample)
ZA (1) ZA201303035B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI578983B (zh) * 2010-10-27 2017-04-21 波麥堤克藥學Smt有限公司 用於治療癌症的化合物及組成物
TWI742541B (zh) 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
RU2560702C1 (ru) * 2014-06-05 2015-08-20 Общество с ограниченной ответственностью "Научно-производственный центр "Амфион" (ООО "НПЦ "Амфион") Фармацевтическая композиция для применения в онкологии
ES2794782T3 (es) * 2014-10-10 2020-11-19 Liminal Biosciences Ltd Compuestos de carboxilato de fenilcetona y composiciones farmacéuticas para la prevención y el tratamiento de la osteoporosis
US20180228750A1 (en) * 2014-10-10 2018-08-16 Prometic Pharma Smt Limited Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
UY36399A (es) 2014-11-12 2016-06-30 Prometic Biosciences Inc Compuestos aromáticos sustituidos y composiciones farmacéuticas para la autoreparación y regeneración del tejido
CN106267213A (zh) * 2015-05-27 2017-01-04 聊城市奥润生物医药科技有限公司 环二核苷酸cGAMP在治疗肿瘤联合用药中的应用
CA3071014A1 (en) 2017-07-25 2019-01-31 Taris Biomedical Llc Methods of treating tumor metastasis
JP2021502347A (ja) 2017-11-08 2021-01-28 タリス バイオメディカル エルエルシー ゲムシタビンを使用した膀胱癌の治療及び維持療法の方法
WO2020113340A1 (en) * 2018-12-05 2020-06-11 Liminal Biosciences Limited Use of sodium 2-(3-pentylphenyl)acetate in the treatment of alström syndrome
US11246945B2 (en) 2019-06-07 2022-02-15 National Defense Medical Center Cisplatin-loaded microbubbles, pharmaceutical composition for treatment of cancer, method for preparing pharmaceutical compositions and method for treating cancer
EP4464688A1 (en) 2019-07-26 2024-11-20 Espervita Therapeutics, Inc. Functionalized long-chain hydrocarbon mono- and di-carboxylic acids useful for the prevention or treatment of disease
AU2021356346A1 (en) * 2020-10-06 2023-06-15 Pharmaceutique Ingenew Inc. Substituted aromatic compounds and pharmaceutical compositions thereof
CA3209453A1 (en) 2021-01-25 2022-07-28 Espervita Therapeutics, Inc. Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives therof, and their use for the prevention or treatment of disease
CN114436822B (zh) * 2022-01-12 2024-04-16 厦门稀土材料研究所 一枝蒿酮酸和生物碱复盐及其制备方法和用途
EP4683624A1 (en) * 2023-03-22 2026-01-28 UTI Limited Partnership Hydroxyphenyl propanoate compounds for tumour immunotherapy, compositions and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0268907A3 (en) * 1986-11-19 1990-03-21 Carl Richard Thornfeldt Treatment of disease conditions relating to hyperactive organelles
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
ITMI20012434A1 (it) * 2001-11-20 2003-05-20 Dompe Spa Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono
CN1169768C (zh) * 2002-04-26 2004-10-06 中国科学院上海有机化学研究所 (4-炔基)-芳香酮酸类化合物、合成方法及应用
US7863428B2 (en) * 2002-12-27 2011-01-04 Tibotec Bvba Fluorogenic enzyme substrates and methods of preparation
WO2005010202A2 (en) * 2003-07-16 2005-02-03 Ligand Pharmacueticals Incorporated PHENYL ACETIC ACID DERIVATIVES AS HEPATOCYTE NUCLEAR FACTOR 4α (HNF-4α) MODULATOR COMPOUNDS
WO2005009104A2 (en) * 2003-07-16 2005-02-03 Ligand Pharmacueticals Incorporated Benzoic and phenyl acetic acid derivatives as hnf-4 modulators
US8198328B2 (en) * 2004-01-21 2012-06-12 New York University Treatment of cancer using benzoic acid derivatives
AU2007290960B2 (en) 2006-09-01 2013-04-18 Piramal Enterprises Limited Anticancer use of caffeic acid and its derivatives
CN105233294A (zh) * 2007-02-08 2016-01-13 爱密斯菲尔科技公司 苯烷基羧酸输送剂
WO2009055932A1 (en) * 2007-11-02 2009-05-07 Prometic Biosciences Inc. Substituted phenylpropionic acids as stimulators of hematopoiesis and erythropoiesis
AU2008318196B2 (en) * 2007-11-02 2014-04-10 Prometic Pharma Smt Limited Medium-chain length fatty acids and glycerides as nephroprotection agents
MX2010006867A (es) * 2007-12-19 2010-08-31 Prometic Biosciences Inc Acidos grasos de longitud de cadena media, sales y trigliceridos en combinacion con gemcitabina para el tratamiento de cancer pancreatico.
PL2427417T3 (pl) * 2009-05-04 2014-03-31 Prometic Pharma Smt Ltd Sole kwasu 3-pentylofenylooctowego i ich farmaceutyczne zastosowania
PL2427416T3 (pl) * 2009-05-04 2016-09-30 Podstawione związki aromatyczne i ich zastosowania farmaceutyczne
TWI578983B (zh) * 2010-10-27 2017-04-21 波麥堤克藥學Smt有限公司 用於治療癌症的化合物及組成物

Similar Documents

Publication Publication Date Title
JP2013544799A5 (enExample)
JP2014528467A5 (enExample)
NZ610851A (en) Compounds and compositions for the treatment of cancer
JP2013507423A5 (enExample)
JP2018507197A5 (enExample)
MX2009004715A (es) Compuestos heterociclicos como agentes antiinflamatorios.
JP2016503414A5 (enExample)
JP2017521420A5 (enExample)
JP2006504624A5 (enExample)
JP2019529518A5 (enExample)
JP2015522650A5 (enExample)
JP2009543802A5 (enExample)
JP2016513737A5 (enExample)
JP2013543845A5 (enExample)
NZ710745A (en) Pyrrolobenzodiazepines and conjugates thereof
SI2970216T1 (en) Biaryl-amide compounds as kinase inhibitors
JP2015531366A5 (enExample)
JP2011251990A5 (enExample)
JP2014518882A5 (enExample)
GEP201606540B (en) New indolizine derivatives, method for their preparation and pharmaceutical compositions containing thereof
JP2014524441A5 (enExample)
RU2005118417A (ru) Комбинированное введение индолинона с химиотерапевтическим средством при нарушениях, вызванных клеточной пролиферацией
GEP201706735B (en) Kinase inhibitors
RU2015149527A (ru) Производные доластатина 10 и ауристатинов
JP2017503833A5 (enExample)